Advisor Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Advisor Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$2.86M	Buy	10,133 +1,403	+16%	+$395K	0.2%	99
2022 Q1	$2.28M	Buy	8,730 +2,678	+44%	+$699K	0.14%	143
2021 Q4	$1.33M	Buy	6,052 +1,213	+25%	+$267K	0.08%	241
2021 Q3	$878K	Sell	4,839 -650	-12%	-$118K	0.06%	304
2021 Q2	$1.11M	Sell	5,489 -924	-14%	-$186K	0.07%	264
2021 Q1	$1.38M	Sell	6,413 -465	-7%	-$99.9K	0.1%	202
2020 Q4	$1.63M	Sell	6,878 -731	-10%	-$173K	0.12%	162
2020 Q3	$2.07M	Sell	7,609 -201	-3%	-$54.7K	0.18%	109
2020 Q2	$2.27M	Buy	7,810 +623	+9%	+$181K	0.21%	93
2020 Q1	$1.71M	Buy	7,187 +1,215	+20%	+$289K	0.21%	106
2019 Q4	$1.4M	Buy	5,972 +332	+6%	+$77.7K	0.14%	141
2019 Q3	$956K	Buy	5,640 +225	+4%	+$38.1K	0.12%	187
2019 Q2	$993K	Sell	5,415 -450	-8%	-$82.5K	0.12%	172
2019 Q1	$1.08M	Buy	5,865 +4	+0.1%	+$736	0.14%	150
2018 Q4	$971K	Buy	5,861 +795	+16%	+$132K	0.16%	142
2018 Q3	$976K	Sell	5,066 -14	-0.3%	-$2.7K	0.13%	158
2018 Q2	$863K	Buy	5,080 +23	+0.5%	+$3.91K	0.15%	160
2018 Q1	$824K	Buy	5,057 +58	+1%	+$9.45K	0.15%	149
2017 Q4	$790K	Sell	4,999 -52	-1%	-$8.22K	0.14%	161
2017 Q3	$768K	Buy	5,051 +26	+0.5%	+$3.95K	0.15%	146
2017 Q2	$648K	Buy	5,025 +860	+21%	+$111K	0.15%	164
2017 Q1	$455K	Buy	4,165 +981	+31%	+$107K	0.12%	212
2016 Q4	$235K	Buy	3,184 +146	+5%	+$10.8K	0.07%	343
2016 Q3	$265K	Buy	3,038 +170	+6%	+$14.8K	0.09%	289
2016 Q2	$247K	Buy	+2,868	New	+$247K	0.09%	281
2016 Q1	–	Sell	-2,735	Closed	-$344K	–	417
2015 Q4	$344K	Sell	2,735 -101	-4%	-$12.7K	0.12%	183
2015 Q3	$295K	Buy	2,836 +147	+5%	+$15.3K	0.12%	199
2015 Q2	$319K	Buy	2,689 +246	+10%	+$29.2K	0.12%	213
2015 Q1	$288K	Buy	2,443 +71	+3%	+$8.37K	0.12%	224
2014 Q4	$282K	Buy	2,372 +357	+18%	+$42.4K	0.12%	216
2014 Q3	$226K	Buy	+2,015	New	+$226K	0.13%	203